The transient receptor potential vanilloid-responsive 1 and 4 cation channels: Role in neuronal osmosensing and renal physiology

Current Opinion in Nephrology and Hypertension

Volumn 16, Issue 5, 2007, Pages 451-458

  Cohen, David M ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hypernatremia; Hypertension; Hyponatremia; Hypotension; Kidney

Indexed keywords

CATION CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL VANILLOID RESPONSIVE 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL VANILLOID RESPONSIVE 4; UNCLASSIFIED DRUG; VANILLOID RECEPTOR;

BRAIN; HUMAN; KIDNEY FUNCTION; MUSCLE HYPOTONIA; NERVE CELL; NONHUMAN; OSMOREGULATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; HYPERNATREMIA; HYPERTENSION; HYPOTENSION; KIDNEY; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEURONS; TRPV CATION CHANNELS; WATER-ELECTROLYTE BALANCE;

EID: 34547864302     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32821f6060     Document Type: Review

References (92)

1. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006; 355:2099-2112. This and the following reference demonstrate promising efficacy for pharmacological inhibition of the vasopressin V2 receptor as therapy for pathological water retention in humans.
2. Soupart A, Gross P, Legros J-J, et al. Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with Satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol 2006; 1:1154-1160. This and the preceding reference demonstrate promising efficacy for pharmacological inhibition of the vasopressin V2 receptor as therapy for pathological water retention in humans.
3. Miller M. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management. J Am Geriatr Soc 2006; 54:345-353.
4. Vachharajani TJ, Zaman F, Abreo KD. Hyponatremia in critically ill patients. J Intensive Care Med 2003; 18:3-8.
5. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342:1581-1589.
6. Allison SP, Lobo DN. Fluid and electrolytes in the elderly. Curr Opin Clin Nutr Metab Care 2004; 7:27-33.
7. Kugler JP, Hustead T. Hyponatremia and hypernatremia in the elderly. Am Fam Physician 2000; 61:3623-3630.
8. Gross P. Correction of hyponatremia. Semin Nephrol 2001; 21:269-272.
9. Caird FI, Andrews GR, Kennedy RD. Effect of posture on blood pressure in the elderly. Br Heart J 1973; 35:527-530.
10. Miller M, Hecker MS, Friedlander DA, Carter JM. Apparent idiopathic hyponatremia in an ambulatory geriatric population. J Am Geriatr Soc 1996; 44:404-408.
11. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia: review and analysis of 129 reported patients. Chest 1993; 103:601-606.
12. Liu BA, Mittmann N, Knowles SR, Shear NH. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. CMAJ 1996; 155:519-527.
13. Fabian TJ, Amico JA, Kroboth PD, et al. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Arch Intern Med 2004; 164:327-332.
14. Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73:257-267.
15. Borroni G,Maggi A, Sangiovanni A, et al. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis 2000; 32:605-610.
16. Tierney WM, Martin DK, Greenlee MC, et al. The prognosis of hyponatremia at hospital admission. J Gen Intern Med 1986; 1:380-385.
17. Goldberg A, Hammerman H, Petcherski S, et al. Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction. Am J Med 2004; 117:242-248.
18. Sterns RH. Severe symptomatic hyponatremia: treatment and outcome: a study of 64 cases. Ann Intern Med 1987; 107:656-664.
19. Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119:71.e1-8. An interesting documentation of the reversible neurological sequelae accompanying even mild water retention in human subjects.
20. Bourque CW. Osmoregulation of vasopressin neurons: a synergy of intrinsic and synaptic processes. Prog Brain Res 1998; 119:59-76.
21. Montell C, Jones K, Hafen E, Rubin G. Rescue of the Drosophila phototransduction mutation trp by germline transformation. Science 1985; 230:1040-1043.
22. Montell C, Rubin GM. Molecular characterization of the Drosophila trp locus: a putative integral membrane protein required for phototransduction. Neuron 1989; 2:1313-1323.
23. Minke B. Drosophila mutant with a transducer defect. Biophys Struct Mech 1977; 3:59-64.
24. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87:165-217. A noteworthy and comprehensive review from a leading group in the field.
25. Hsu YJ, Hoenderop JG, Bindels RJ. TRP channels in kidney disease. Biochim Biophys Acta 2007 (in press). Another noteworthy and comprehensive review from a leading group in the field.
26. Reiser J, Polu KR, Moller CC, et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37:739-744.
27. Winn MP, Conlon PJ, Lynn KL, et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005;308:1801-1804.
28. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31:166-170.
29. Perry L, Dickau R, Zarrillo S, et al. Starch fossils and the domestication and dispersal of chili peppers (Capsicum spp. L. ) in the Americas. Science 2007; 315:986-988.
30. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389:816-824.
31. Caterina MJ, Leffler A, Malmberg AB, et al. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000; 288:306-313.
32. Jordt SE, Julius D. Molecular basis for species-specific sensitivity to 'hot' chili peppers. Cell 2002; 108:421-430.
33. Colbert HA, Bargmann CI. Odorant-specific adaptation pathways generate olfactory plasticity in C. elegans. Neuron 1995; 14:803-812.
34. Colbert HA, Smith TL, Bargmann CI. OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation, and olfactory adaptation in Caenorhabditis elegans. J Neurosci 1997; 17:8259-8269.
35. Liedtke W, Choe Y, Marti-Renom MA, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000; 103:525-535.
36. Strotmann R, Harteneck C, Nunnenmacher K, et al. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol 2000; 2:695-702.
37. Wissenbach U, Bodding M, Freichel M, Flockerzi V. Trp12, a novel Trp related protein from kidney. FEBS Lett 2000; 485:127-134.
38. Delany NS, Hurle M, Facer P, et al. Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2. Physiol Genomics 2001; 4:165-174.
39. Guler AD, Lee H, Iida T, et al. Caterina M: Heat-evoked activation of the ion channel, TRPV4. J Neurosci 2002; 22:6408-6414.
40. Tian W, Salanova M, Xu H, et al. Renal expression of osmotically responsive cation channel TRPV4 is restricted to water-impermeant nephron segments. Am J Physiol Renal Physiol 2004; 287:F17-F24.
41. Mizuno A, Matsumoto N, Imai M, Suzuki M. Impaired osmotic sensation in mice lacking TRPV4. Am J Physiol Cell Physiol 2003; 285:C96-C101.
42. Liedtke W, Friedman JM. Abnormal osmotic regulation in trpv4-/- mice. Proc Natl Acad Sci U S A 2003; 100:13698-13703.
43. Xu H, Zhao H, Tian W, et al. Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J Biol Chem 2003; 278:11520-11527.
44. Vriens J, Watanabe H, Janssens A, et al. Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc Natl Acad Sci U S A 2004; 101:396-401.
45. Alessandri-Haber N, Yeh JJ, Boyd AE, et al. Hypotonicity induces TRPV4-mediated nociception in rat. Neuron 2003; 39:497-511.
46. Cohen D. SRC family kinases in cell volume regulation. Am J Physiol Cell Physiol 2005; 288:C483-C493.
47. Hisatsune C, Kuroda Y, Nakamura K, et al. Regulation of TRPC6 channel activity by tyrosine phosphorylation. J Biol Chem 2004; 279:18887-18894.
48. Jiang X, Newell EW, Schlichter LC. Regulation of a TRPM7-like current in rat brain microglia. J Biol Chem 2003; 278:42867-42876.
49. Jin X, Morsy N, Winston J, et al. Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am J Physiol Cell Physiol 2004; 287:C558-C563.
50. Vazquez G, Wedel BJ, Kawasaki BT, et al. Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels. J Biol Chem 2004; 279:40521-40528.
51. Watanabe H, Vriens J, Prenen J, et al. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 2003; 424:434-438.
52. Vriens J, Owsianik G, Fisslthaler B, et al. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res 2005; 97:908-915.
53. Thoroed SM, Lauritzen L, Lambert IH, et al. Cell swelling activates phospholipase A2 in Ehrlich ascites tumor cells. J Membr Biol 1997; 160:47-58.
54. Basavappa S, Pedersen SF, Jorgensen NK, et al. Swelling-induced arachidonic acid release via the 85-kDa cPLA2 in human neuroblastoma cells. J Neurophysiol 1998; 79:1441-1449.
55. Pedersen S, Lambert IH, Thoroed SM, Hoffmann EK. Hypotonic cell swelling induces translocation of the alpha isoform of cytosolic phospholipase A2 but not the gamma isoform in Ehrlich ascites tumor cells. Eur J Biochem 2000; 267:5531-5539.
56. Arniges M, Vazquez E, Fernandez-Fernandez JM, Valverde MA. Swelling-activated Ca2+ entry via TRPV4 channel is defective in cystic fibrosis airway epithelia. J Biol Chem 2004; 279:54062-54068.
57. Becker D, Blase C, Bereiter-Hahn J, Jendrach M. TRPV4 exhibits a functional role in cell-volume regulation. J Cell Sci 2005; 118:2435-2440.
58. Liu X, Bandyopadhyay B, Nakamoto T, et al. A role for AQP5 in activation of TRPV4 by hypotonicity: concerted involvement of AQP5 and TRPV4 in regulation of cell volume recovery. J Biol Chem 2006; 281:15485-15495. This and the following study reflect an emerging appreciation of the functional interaction between TRPV4 and the apically expressed pulmonary alveolar epithelial water channel, aquaporin-5.
59. Sidhaye VK, Guler AD, Schweitzer KS, et al. Transient receptor potential vanilloid 4 regulates aquaporin-5 abundance under hypotonic conditions. Proc Natl Acad Sci U S A 2006; 103:4747-4752. This study, along with the preceding study, addresses the functional interaction between TRPV4 and aquaporin-5.
60. Gao X, Wu L, O'Neil RG. Temperature-modulated diversity of TRPV4 channel gating: activation by physical stresses and phorbol ester derivatives through protein kinase C-dependent and -independent pathways. J Biol Chem 2003; 278:27129-27137.
61. Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. J Biol Chem 2003; 278:22664-22668.
62. Andrade YN, Fernandes J, Vazquez E, et al. TRPV4 channel is involved in the coupling of fluid viscosity changes to epithelial ciliary activity. J Cell Biol 2005; 168:869-874.
63. Muraki K, Iwata Y, Katanosaka Y, et al. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res 2003; 93:829-838.
64. Birder LA, Nakamura Y, Kiss S, et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 2002; 5:856-860.
65. Birder LA, Kanai AJ, de Groat WC, et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci U S A 2001; 98:13396-13401.
66. Rong W, Hillsley K, Davis JB, et al. Jejunal afferent nerve sensitivity in wild-type and TRPV1 knockout mice. J Physiol 2004; 560:867-881.
67. Scotland RS, Chauhan S, Davis C, et al. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction. Circ Res 2004; 95:1027-1034.
68. Sharif Naeini R, Witty MF, Seguela P, Bourque CW. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci 2006; 9:93-98. An extraordinary report strongly suggesting that a splice variant of TRPV1 is instrumental in the central response to systemic hypertonicity. Although the authors were able to PCR-amplify a portion of the TRPV1 cDNA from magnocellular (vasopressin-producing) neurons, they were unable to amplify a full-length clone. This led them to speculate that a potentially novel splice variant of TRPV1 was required.
69. Zhang Z, Bourque CW. Osmometry in osmosensory neurons. Nat Neurosci 2003; 6:1021-1022.
70. McKinley MJ, Gerstberger R, Mathai ML, et al. The lamina terminalis and its role in fluid and electrolyte homeostasis. J Clin Neurosci 1999; 6:289-301.
71. Ciura S, Bourque CW. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci 2006; 26:9069-9075. A follow-up observation to reference 68, wherein hypertonicity responsiveness was demonstrated in the 'upstream' neurons of the lamina terminalis, in contrast to the 'downstream' magnocellular (vasopressin- producing) neurons investigated in the earlier report.
72. Mezey E, Toth ZE, Cortright DN, et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A 2000; 97:3655-3660.
73. Chandrashekar J, Hoon MA, Ryba NJ, Zuker CS. The receptors and cells for mammalian taste. Nature 2006; 444:288-294.
74. Huang AL, Chen X, Hoon MA, et al. The cells and logic for mammalian sour taste detection. Nature 2006; 442:934-938.
75. Lyall V, Heck GL, Vinnikova AK, et al. The mammalian amiloride-insensitive nonspecific salt taste receptor is a vanilloid receptor-1 variant. J Physiol 2004; 558:147-159.
76. Schumacher MA, Moff I, Sudanagunta SP, Levine JD. Molecular cloning of an N-terminal splice variant of the capsaicin receptor: loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes. J Biol Chem 2000; 275:2756-2762.
77. Suzuki M, Sato J, Kutsuwada K, et al. Cloning of a stretch-inhibitable nonselective cation channel. J Biol Chem 1999; 274:6330-6335.
78. Wang C, Hu HZ, Colton CK, et al. An alternative splicing product of the murine trpv1 gene dominant negatively modulates the activity of TRPV1 channels. J Biol Chem 2004; 279:37423-37430.
79. Lu G, Henderson D, Liu L, et al. TRPV1b: a functional human vanilloid receptor splice variant. Mol Pharmacol 2005; 67:1119-1127.
80. Tian W, Fu Y, Wang DH, Cohen DM. Regulation of TRPV1 by a novel renally expressed rat TRPV1 splice variant. Am J Physiol Renal Physiol 2006; 290:F117-F126.
81. Cohen D. TRPV4 and the mammalian kidney. Pflugers Arch 2005; 451:168-175.
82. Teilmann SC, Byskov AG, Pedersen PA, et al. Localization of transient receptor potential ion channels in primary and motile cilia of the female murine reproductive organs. Mol Reprod Dev 2005; 71:444-452. An abstract localizing TRPV4 expression to the mechanosensory apical cilium of renal epithelial cells in culture, and suggesting a functional interaction with polycystin-2.
83. Koettgen M, Bucholz B, Steffl D, et al. Polycystin-2 and TRPV4 form a functional heteromultimeric complex that might act as a cilial mechanosensor [abstract]. J Am Soc Nephrol 2005; 16:25A. An abstract localizing TRPV4 expression to the mechanosensory apical cilium of renal epithelial cells in culture, and suggesting a functional interaction with polycystin-2.
84. -/- mice.
85. Reiter B, Kraft R, Gunzel D, et al. TRPV4-mediated regulation of epithelial permeability. Faseb J 2006; 20:1802-1812. An analysis of effector pathways following TRPV4 activation that may be involved in mediating transcellular ion flux.
86. Cortright DN, Crandall M, Sanchez JF, et al. The tissue distribution and functional characterization of human VR1. Biochem Biophys Res Commun 2001; 281:1183-1189.
87. Sanchez JF, Krause JE, Cortright DN. The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat. Neuroscience 2001; 107:373-381.
88. Kopp UC, Smith LA. Inhibitory renorenal reflexes: a role for substance P or other capsaicin-sensitive neurons. Am J Physiol 1991; 260:R232-R239.
89. Zhu Y, Wang Y, Wang DH. Diuresis and natriuresis caused by activation of VR1-positive sensory nerves in renal pelvis of rats. Hypertension 2005; 46:992-997.
90. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77:75-197.
91. Wang Y, Wang DH. Neural control of blood pressure: focusing on capsaicin-sensitive sensory nerves. Cardiovasc Hematol Disord Drug Targets 2007; 7:37-46.
92. Toney GM, Chen QH, Cato MJ, Stocker SD. Central osmotic regulation of sympathetic nerve activity. Acta Physiol Scand 2003; 177:43-55.